Fig. 7From: LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signalingProposed model for the biological role of LINC02159 in NSCLC progression. LINC02159 bounds to ALYREF to enhance the stability of YAP1 mRNA via m5C modification, leading to the overexpression of YAP1 and the activation of the Hippo and Wnt/β-catenin pathways, ultimately promoting the progression of NSCLC.Back to article page